CYP2E1 Antibody

About the Target

Cytochrome P450 2E1 (CYP2E1), an ethanol-metabolizing enzyme, is a member of the cytochrome P450 superfamily of heme-containing monooxygenases that catalyze the oxidative metabolism of a wide range of endogenous and exogenous compounds. Structurally, CYP2E1 is an endoplasmic reticulum-anchored enzyme composed of a hydrophobic N-terminal membrane-binding domain and a conserved catalytic heme-binding domain that facilitates electron transfer from NADPH-cytochrome P450 reductase to substrates. Depending on the literature source, CYP2E1 may also be discussed as 1F12G7 and 4-nitrophenol 2-hydroxylase.

Reported cellular context includes endoplasmic reticulum, membrane, microsome, and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following CYP2E1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CYP2E1 is commonly interpreted in the context of cancer, metabolism, and oxidative stress research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endoplasmic reticulum, membrane, and microsome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between endoplasmic reticulum, membrane, and microsome across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• redox-associated shifts that may alter abundance, localization, or pathway coupling

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CYP2E1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CYP2E1 reflect biology rather than handling. When interpreting CYP2E1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CYP2E1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.